Lexaria Bioscience Corp. (NASDAQ:LEXX) Position Raised by Invenomic Capital Management LP

Invenomic Capital Management LP raised its stake in Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) by 62.0% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 766,573 shares of the company’s stock after buying an additional 293,470 shares during the quarter. Invenomic Capital Management LP owned approximately 9.48% […]

Related Keywords

Lexaria Bioscience ,Susquehanna International Group ,Virtu Financial ,Lexaria Bioscience Corp ,Nasdaq ,Dimensional Fund Advisors ,Lexaria Bioscience Company Profile ,Renaissance Technologies ,Invenomic Capital Management ,Free Report ,Capital Management ,International Group ,Fund Advisors ,Bioscience Stock Down ,Visit Holdingschannel ,Lexaria Bioscience Daily ,Nasdaq Lexx ,Lexx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,